SMS PHARMACEUTICALS LTD. - 532815 - Compliance Not Applicable To The Company
Provision of "LARGE CORPORATE" and "STATEMENT FOR DEVIATION OR VARIATION" are applicable to the Company as on March 31, 202030-06-2020
30-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - Closure of Trading Window
This is to informed that the Trading window closure period pursuant to SMS Pharmaceuticals Limited code to Regulate, Monitor and Report Trading by Directors, Promoters, Designated employees and Specified connected persons of the Company will commence from 1st July, 2020 and end of 48 hours after the declaration of the Un Audited financial results of the Company for the first Quarter ending 30th June, 2020. This is for your information and records30-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - Intimation Received From The Promoters For The Withdrawal Of Intimation Given Under Regulation 10(5) Of The SEBI (SAST) Regulations, 2011
We would like to inform that the intimation of the proposal to acquire 54,67,000 (Fifty four lakhs sixty seven thousand) equity Shares (6.46%) of SMS Pharmaceuticals Limited ('Target Company') by Mr. Vamsi Krishna Potluri from Mr.Veeravenkat Satyanarana Murthy Talluri , as an inter-se transfer between members of Promoters / Promoters' Group / Persons acting in concert under Regulation 10(1)(a)(ii) of SEBI (SAST) Regulations, 2011, was submitted to your office under Regulation 10(5) of the said regulations on 22.06.2020 under reference (i) above. Now, the Company has been informed by the acquirer that the proposal to acquire the said shares under the Regulation 10(5) of SEBI (SAST) Regulation's, 2011 by the acquirer has been withdrawn and we have received the withdrawal intimation vide letter dated 25/06/2020(Copy enclosed) from the acquirer.25-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - Intimation Received From The Promoters For The Withdrawal Of Intimation Given Under Regulation 10(5) Of The SEBI (SAST) Regulations, 2011
We would like to inform that the intimation of the proposal to acquire 26,50,000 (twenty six lakhs, fifty thousand)equity Shares (3.13%) of SMS Pharmaceuticals Limited ('Target Company') by Mr. Ramesh Babu Potluri from Mrs. Annapurna Talluri, as an inter-se transfer between members of Promoters / Promoters' Group / Persons acting in concert under Regulation 10(1)(a)(ii) of SEBI (SAST) Regulations, 2011, was submitted to your office under Regulation 10(5) of the said regulations on 22.06.2020 under reference (i) above. Now, the Company has been informed by the acquirer that the proposal to acquire the said shares under the Regulation 10(5) of SEBI (SAST) Regulation's, 2011 by the acquirer has been withdrawn and we have received the withdrawal intimation vide letter dated 25/06/2020(Copy enclosed) from the acquirer.25-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - Updates on Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
Vamsi Krishna Potluri has informed the Exchange about withdrawal of its earlier disclosures dated 22.06.2020, submitted under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 201125-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - Updates on Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
Ramesh Babu Potluri has informed the Exchange about withdrawal of its earlier disclosures dated 22.06.2020, submitted under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 201125-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - Intimation Received From Mr. Vamsi Krishna Potlurifor The Proposed Acquisition Under Regulation 10(5) Of The SEBI (SAS1) Regulation, 201L.
We have received the intimation under Regulation 10(5) of SEBI (Substantial Acquisition Shares Takeovers) Regulations, 2011 for the proposed acquisition of 54,67,000 (Fifty four lakhs sixty seven thousand)Equity shares (6.46%) of the Company from the acquirer namely, Mr. Vamsi Krishna Potluri to acquire the shares from Mr. Veeravenkata Satyanarayana Murthy Talluri, as inter-se transfer of equity shares between the promoters and promoters group. This information is submitted to the Stock Exchanges pursuant to the Regulation 3(ii) of SEBI (Prohibition of Insider Trading) Regulations, 2015 as Unpublished Price Sensitive Information (UPSI). A copy of the intimation letter dated 22nd June, 2020 received from the acquirer is attached.22-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - Intimation Received From Mr. Ramesh Babu Potluri For The Proposed Acquisition Under Regulation 10(5) Of The SEBI (SAS1) Regulation, 201L. -
We have received the intimation under Regulation 10(5) of SEBI (Substantial Acquisition Shares Takeovers) Regulations, 2011 for the proposed acquisition of 26,50,000 ( Twenty six lakhs fifty thousand) Equity shares (3.13%) of the Company from the acquirer namely, Mr. Ramesh Babu Potluri to acquire the shares from Mrs. Annapurna Talluri, as inter-se transfer of equity shares between the promoters and promoters group. This information is submitted to the Stock Exchanges Pursuant to the Regulation 3(ii) of SEBI (Prohibition of Insider Trading) Regulations, 2015 as unpublished Price Sensitive Information (UPSI). A copy of the intimation letter dated 22nd June, 2020 received from the acquirer is attached.22-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vamsi Krishna Potluri22-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramesh Babu Potluri22-06-2020